32
Participants
Start Date
December 1, 2025
Primary Completion Date
December 1, 2027
Study Completion Date
December 1, 2027
Endurance Exercise Therapy
"* Exercise: Endurance exercise therapy comprising treadmill walking administered by exercise physiologists via a study-kit which includes a smart-watch (activity tracker), heart rate monitor, blood pressure cuff, body composition scale, and etablet)~* Exercise escalation trial testing 3 exercise levels (150, 225, and 300 minutes per week), with one de-escalation exercise of 90 minutes per week, if required.~* The phase 1b trial will evaluate the highest feasible exercise level and one exercise below identified in the phase 1a study."
Memorial Sloan Kettering Cancer Center, New York
Cleveland Clinic Foundation, Cleveland
University of Michigan Rogel Cancer Center, Ann Arbor
National Cancer Institute (NCI)
NIH
University of Michigan Rogel Cancer Center
OTHER